Book an appointment

Psychiatry

Adult ADHD evaluation and treatment in China

Structured adult ADHD evaluation programmes at Class A psychiatry departments — diagnostic workup, validated rating scales, and stimulant + non-stimulant treatment options at substantially lower cost than Western private pay.

← All conditions

Overview

Adult ADHD is one of the most-undertreated psychiatric conditions globally — partly because formal evaluation in many Western markets has wait times measured in months and out-of-pocket costs of USD 800–2,500. Class A academic psychiatry departments in China offer structured evaluation programmes for international patients with shorter wait times and substantially lower costs.

Common symptoms

  • Persistent inattention — difficulty organising, finishing tasks, sustaining attention
  • Hyperactivity / restlessness
  • Impulsivity — interrupting, decisions without considering consequences
  • Onset typically in childhood; adult presentation often more inattentive than hyperactive
  • Comorbid anxiety, depression, sleep disturbance frequently present

Risk factors

  • Family history (highly heritable)
  • Childhood symptoms — the diagnosis requires evidence of childhood-onset

Standard diagnostic workup

Cost band at Class A international department: USD 260–420 all-in.

  • Structured clinical interview (60–90 minutes)
  • Validated rating scales (ASRS-v1.1, Conners adult, DIVA-5)
  • Childhood corroboration (school reports, family history) where feasible
  • Differential rule-out: depression (PHQ-9), anxiety (GAD-7), sleep, thyroid, substance use
  • Brief cognitive testing where attention complaints predominate

Treatment options

First-line

Methylphenidate (Concerta extended-release)

First-line stimulant for adult ADHD. Tightly regulated; ongoing prescription requires confirmed diagnosis.

First-line

Lisdexamfetamine (Vyvanse)

Available at academic centres with specialist prescribing.

First-line

Atomoxetine (Strattera)

Non-stimulant alternative; useful when stimulants contraindicated or anxiety comorbid.

First-line

Cognitive behavioural therapy for ADHD

Strong adjunct evidence; available in English-speaking format at major centres.

First-line

Coaching / executive-function support

Increasingly integrated into multidisciplinary ADHD programmes.

Second-line

Bupropion

Off-label use with growing evidence.

Frequently asked

Do I have ADHD?
Take our free ASRS-v1.1 6-item self-screener developed by the WHO. ≥4 items endorsed positive = strong indicator that a structured evaluation is warranted.
Are ADHD medications available in China?
Yes. Both stimulant (methylphenidate including Concerta, lisdexamfetamine) and non-stimulant (atomoxetine, bupropion) options are available through licensed psychiatry departments. Stimulants are tightly regulated; ongoing prescription requires a confirmed diagnosis.
How long does evaluation take?
Plan for a 5–7 day visit: 1 day for evaluation, 1–2 days for any add-on testing or labs, plus a follow-up consult to start titration. Subsequent dose adjustments can be coordinated via telehealth.
Self-assessment

Adult ADHD self-screener (ASRS-v1.1)

The 6-item Part A of the WHO Adult ADHD Self-Report Scale. Validated screen for adults 18+. Not a diagnosis — but a strong indicator of whether a full evaluation is warranted.

Take the Adult ADHD screener

Related specialty

Psychiatry hub →

Further reading

Psychiatry

Adult ADHD Diagnosis Pathway in China for International Patients

Class A psychiatry departments in China now run structured adult ADHD evaluation programmes for international patients. Here is the full workflow, what it costs, and what changes in your treatment options once diagnosed.

Talk to a senior physician

Free 30-minute video consult to review your case. We'll quote a workup and treatment plan at a Class A partner hospital — no commitment.

Book free consult